Enediyne-activated, EGFR-targeted human β-defensin 1 has therapeutic efficacy against non-small cell lung carcinoma
Wenjuan Liu(Fudan University), Hui Zhu(Anhui Medical University)
Cited by 14
Related Papers
Combined Oral Administration of GABA and DPP-4 Inhibitor Prevents Beta Cell Damage and Promotes Beta Cell Regeneration in Mice
|Frontiers in Pharmacology|2017|50
Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats
|Journal of Diabetes Research|2018|44